
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Reversal of Bortezomib Resistance in Myelodysplastic Syndrome Cells by MAPK Inhibitors - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC50000275E9695E4E9.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="plosone" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC3946707/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946707/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS ONE" /><meta name="citation_title" content="Reversal of Bortezomib Resistance in Myelodysplastic Syndrome Cells by MAPK Inhibitors" /><meta name="citation_author" content="Yingxing Yue" /><meta name="citation_author_institution" content="Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, First Affiliated Hospital, Soochow University, Suzhou, China" /><meta name="citation_author" content="Ying Wang" /><meta name="citation_author_institution" content="Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China" /><meta name="citation_author" content="Yang He" /><meta name="citation_author_institution" content="Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China" /><meta name="citation_author" content="Shuting Yang" /><meta name="citation_author_institution" content="Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, First Affiliated Hospital, Soochow University, Suzhou, China" /><meta name="citation_author" content="Zixing Chen" /><meta name="citation_author_institution" content="Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China" /><meta name="citation_author" content="Yuanyuan Wang" /><meta name="citation_author_institution" content="Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China" /><meta name="citation_author" content="Shanshan Xing" /><meta name="citation_author_institution" content="Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, First Affiliated Hospital, Soochow University, Suzhou, China" /><meta name="citation_author" content="Congcong Shen" /><meta name="citation_author_institution" content="Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, First Affiliated Hospital, Soochow University, Suzhou, China" /><meta name="citation_author" content="Hesham M. Amin" /><meta name="citation_author_institution" content="Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America" /><meta name="citation_author" content="Depei Wu" /><meta name="citation_author_institution" content="Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China" /><meta name="citation_author" content="Yao-Hua Song" /><meta name="citation_author_institution" content="Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, First Affiliated Hospital, Soochow University, Suzhou, China" /><meta name="citation_publication_date" content="2014" /><meta name="citation_issue" content="3" /><meta name="citation_volume" content="9" /><meta name="citation_doi" content="10.1371/journal.pone.0090992" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3946707/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC3946707/" /><meta name="citation_pmid" content="24608798" /><meta name="DC.Title" content="Reversal of Bortezomib Resistance in Myelodysplastic Syndrome Cells by MAPK Inhibitors" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="PLOS" /><meta name="DC.Contributor" content="Yingxing Yue" /><meta name="DC.Contributor" content="Ying Wang" /><meta name="DC.Contributor" content="Yang He" /><meta name="DC.Contributor" content="Shuting Yang" /><meta name="DC.Contributor" content="Zixing Chen" /><meta name="DC.Contributor" content="Yuanyuan Wang" /><meta name="DC.Contributor" content="Shanshan Xing" /><meta name="DC.Contributor" content="Congcong Shen" /><meta name="DC.Contributor" content="Hesham M. Amin" /><meta name="DC.Contributor" content="Depei Wu" /><meta name="DC.Contributor" content="Yao-Hua Song" /><meta name="DC.Date" content="2014" /><meta name="DC.Identifier" content="10.1371/journal.pone.0090992" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Reversal of Bortezomib Resistance in Myelodysplastic Syndrome Cells by MAPK Inhibitors" /><meta property="og:type" content="article" /><meta property="og:description" content="The myelodysplastic syndromes (MDS) comprise a heterogeneous group of malignant neoplasms with distinctive clinicopathological features. Currently, there is no specific approach for the treatment of MDS. Here, we report that bortezomib (BTZ), a proteasome ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946707/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3946707/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22PLoS%20One%22[journal]" class="navlink">PLoS One</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3946707
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3946707/pdf/pone.0090992.pdf" class="int-view">PDF (1.0M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3946707/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3946707/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3946707" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3946707%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="mwfYh1glPjDRq4XH8ffDttYvrMTFxvYzhR8F0yaZqkrko8gmI6lcxasPddQlIpHv">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3946707%2F&amp;text=Reversal%20of%20Bortezomib%20Resistance%20in%20Myelodysplastic%20Syndrome%20Cells%20by%20MAPK%20Inhibitors" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3946707%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946707/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3946707/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/24608798/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3946707/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/24608798/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3946707/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3946707/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22PLoS%20One%22[journal]" class="navlink">PLoS One</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3946707
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-plosone.png" alt="Logo of plosone" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://journals.plos.org/plosone/" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">PLoS One.</span> 2014; 9(3): e90992. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2014 Mar 7. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1371%2Fjournal.pone.0090992" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0090992</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3946707</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/24608798">24608798</a></div></div></div><h1 class="content-title">Reversal of Bortezomib Resistance in Myelodysplastic Syndrome Cells by MAPK Inhibitors</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yue%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140715424765904" co-class="co-affbox">Yingxing Yue</a>,<sup>#</sup><sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140715421950768" co-class="co-affbox">Ying Wang</a>,<sup>#</sup><sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=He%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140715430974272" co-class="co-affbox">Yang He</a>,<sup>#</sup><sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yang%20S%5BAuthor%5D" class="affpopup" co-rid="_co_idm140715430971888" co-class="co-affbox">Shuting Yang</a>,<sup>#</sup><sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20Z%5BAuthor%5D" class="affpopup" co-rid="_co_idm140715417437952" co-class="co-affbox">Zixing Chen</a>,<sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140715431755248" co-class="co-affbox">Yuanyuan Wang</a>,<sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xing%20S%5BAuthor%5D" class="affpopup" co-rid="_co_idm140715431752880" co-class="co-affbox">Shanshan Xing</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shen%20C%5BAuthor%5D" class="affpopup" co-rid="_co_idm140715425333616" co-class="co-affbox">Congcong Shen</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Amin%20HM%5BAuthor%5D" class="affpopup" co-rid="_co_idm140715422008912" co-class="co-affbox">Hesham M. Amin</a>,<sup>
3
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wu%20D%5BAuthor%5D" class="affpopup" co-rid="_co_idm140715422006544" co-class="co-affbox">Depei Wu</a>,<sup>
2
,</sup><sup>
*
</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Song%20YH%5BAuthor%5D" class="affpopup" co-rid="_co_idm140715419931152" co-class="co-affbox">Yao-Hua Song</a><sup>
1
,</sup><sup>
*
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140715424765904"><h3 class="no_margin">Yingxing Yue</h3><p>
<sup>1</sup>
Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, First Affiliated Hospital, Soochow University, Suzhou, China
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yue%20Y%5BAuthor%5D">Yingxing Yue</a></div></div><div id="_co_idm140715421950768"><h3 class="no_margin">Ying Wang</h3><p>
<sup>2</sup>
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang%20Y%5BAuthor%5D">Ying Wang</a></div></div><div id="_co_idm140715430974272"><h3 class="no_margin">Yang He</h3><p>
<sup>2</sup>
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=He%20Y%5BAuthor%5D">Yang He</a></div></div><div id="_co_idm140715430971888"><h3 class="no_margin">Shuting Yang</h3><p>
<sup>1</sup>
Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, First Affiliated Hospital, Soochow University, Suzhou, China
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yang%20S%5BAuthor%5D">Shuting Yang</a></div></div><div id="_co_idm140715417437952"><h3 class="no_margin">Zixing Chen</h3><p>
<sup>2</sup>
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20Z%5BAuthor%5D">Zixing Chen</a></div></div><div id="_co_idm140715431755248"><h3 class="no_margin">Yuanyuan Wang</h3><p>
<sup>2</sup>
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang%20Y%5BAuthor%5D">Yuanyuan Wang</a></div></div><div id="_co_idm140715431752880"><h3 class="no_margin">Shanshan Xing</h3><p>
<sup>1</sup>
Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, First Affiliated Hospital, Soochow University, Suzhou, China
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xing%20S%5BAuthor%5D">Shanshan Xing</a></div></div><div id="_co_idm140715425333616"><h3 class="no_margin">Congcong Shen</h3><p>
<sup>1</sup>
Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, First Affiliated Hospital, Soochow University, Suzhou, China
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shen%20C%5BAuthor%5D">Congcong Shen</a></div></div><div id="_co_idm140715422008912"><h3 class="no_margin">Hesham M. Amin</h3><p>
<sup>3</sup>
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Amin%20HM%5BAuthor%5D">Hesham M. Amin</a></div></div><div id="_co_idm140715422006544"><h3 class="no_margin">Depei Wu</h3><p>
<sup>2</sup>
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wu%20D%5BAuthor%5D">Depei Wu</a></div></div><div id="_co_idm140715419931152"><h3 class="no_margin">Yao-Hua Song</h3><p>
<sup>1</sup>
Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, First Affiliated Hospital, Soochow University, Suzhou, China
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Song%20YH%5BAuthor%5D">Yao-Hua Song</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Gangjian Qin, <span class="fm-role">Editor</span><sup></sup></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140715418376608_ai idm140715424766032_ai idm140715429923232_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140715418376608_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140715418376608_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140715418376608_ai" style="display:none"><div class="fm-affl" id="aff1">
<sup>1</sup>
Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, First Affiliated Hospital, Soochow University, Suzhou, China
</div><div class="fm-affl" id="aff2">
<sup>2</sup>
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China
</div><div class="fm-affl" id="aff3">
<sup>3</sup>
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
</div><div class="fm-affl" id="edit1">
Northwestern University, United States of America
</div><div><sup>#</sup>Contributed equally.</div><div id="cor1">* E-mail: <a href="mailto:dev@null" data-email="moc.oohay@1gnos_auhoay" class="oemail">moc.oohay@1gnos_auhoay</a> (YHS); <a href="mailto:dev@null" data-email="nc.moc.liamdem@iepeduw" class="oemail">nc.moc.liamdem@iepeduw</a> (DPW)</div><div id="fn-a.l.b.l.b"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</div><div><p class="p p-first-last">Conceived and designed the experiments: YXY YW YH STY ZXC YYW SSX CCS HMA DPW YHS. Performed the experiments: YXY YW YH STY. Analyzed the data: YXY YW YH STY ZXC YYW SSX CCS HMA DPW YHS. Wrote the paper: YXY YW YH STY ZXC YYW SSX CCS HMA DPW YHS.</p></div></div><div class="fm-article-notes hide half_rhythm" id="idm140715418376608_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2013 Nov 24; Accepted 2014 Feb 5.</div></div><div class="permissions half_rhythm hide" id="idm140715418376608_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2014 Yue et al</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="abstract-a.l.b.t" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.l.b.ttitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">The myelodysplastic syndromes (MDS) comprise a heterogeneous group of malignant neoplasms with distinctive clinicopathological features. Currently, there is no specific approach for the treatment of MDS. Here, we report that bortezomib (BTZ), a proteasome inhibitor that has been used to treat plasma cell myeloma, induced G2/M phase cycle arrest in the MDS cell line SKM-1 through upregulation of Wee1, a negative regulator of G2/M phase transition. Treatment by BTZ led to reduced SKM-1 cell viability as well as increased apoptosis and autophagy. The BTZ-induced cell death was associated with reduced expression of p-ERK. To elucidate the implications of downregulation of p-ERK, we established the BTZ resistant cell line SKM-1R. Our data show that resistance to BTZ-induced apoptosis could be reversed by the MEK inhibitors U0126 or PD98059. Our results suggest that MAPK pathway may play an important role in mediating BTZ resistance.</p></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p class="p p-first">The myelodysplastic syndromes (MDS) are a group of clonal disorders characterized by ineffective hematopoietic cell production and variable risk of transformation to acute myeloid leukemia (AML). Treatment options are limited and targeted therapies are not available for MDS. Hematopoietic stem cell transplantation (HSCT) strategies may improve long-term survival in some young patients. However, MDS is primarily a disease of elderly people who are often intolerant to aggressive therapies such as HSCT and chemotherpeutics.</p><p>It has been shown that the proteasome inhibitor bortezomib (BTZ) is effective in the treatment of plasma cell myeloma <a href="#pone.0090992-SanMiguel1" rid="pone.0090992-SanMiguel1" class=" bibr popnode">[1]</a>
<a href="#pone.0090992-Richardson1" rid="pone.0090992-Richardson1" class=" bibr popnode">[2]</a>
<a href="#pone.0090992-Petrucci1" rid="pone.0090992-Petrucci1" class=" bibr popnode">[3]</a>. More recently, BTZ demonstrated some promise in the treatment of MDS and AML <a href="#pone.0090992-Attar1" rid="pone.0090992-Attar1" class=" bibr popnode">[4]</a>&#x02013;<a href="#pone.0090992-NatarajanAme1" rid="pone.0090992-NatarajanAme1" class=" bibr popnode">[7]</a>. In a phase I clinical trial, BTZ combined with weekly idarubicin successfully induced hematologic response in AML patients who have prior history of MDS <a href="#pone.0090992-Howard1" rid="pone.0090992-Howard1" class=" bibr popnode">[5]</a>. Similarly, in a phase I/II trial, BTZ and low dose cytarabine arabinoside showed clinical response in 36% of high-risk MDS patients <a href="#pone.0090992-NatarajanAme1" rid="pone.0090992-NatarajanAme1" class=" bibr popnode">[7]</a>. These studies also demonstrated that BTZ is more effective when combined with other chemotherapeutic agents for treating high-risk MDS patients <a href="#pone.0090992-Howard1" rid="pone.0090992-Howard1" class=" bibr popnode">[5]</a>
<a href="#pone.0090992-NatarajanAme1" rid="pone.0090992-NatarajanAme1" class=" bibr popnode">[7]</a>. Nonetheless, chemotherapy is usually associated with severe side effects that might lead to patient&#x02019;s death. Most likely, targeted therapies that selectively exploit specific survival molecules are more effective and notably associated with fewer side effects. The development of targeted therapies for MDS has been particularly challenging due to the complexity of the oncogenic systems contributing to the survival of MDS cells.</p><p>The MEK/ERK pathway plays key roles in controlling cell survival and cell cycle progression, and its deregulation is often implicated in developing drug resistance and cancer progression. Upregulation of p-ERK has been observed in the majority of AML cases <a href="#pone.0090992-Ricciardi1" rid="pone.0090992-Ricciardi1" class=" bibr popnode">[8]</a>, <a href="#pone.0090992-Kornblau1" rid="pone.0090992-Kornblau1" class=" bibr popnode">[9]</a>, and elevated expression of ERK in AMLs is associated with a poor prognosis <a href="#pone.0090992-Shelton1" rid="pone.0090992-Shelton1" class=" bibr popnode">[10]</a>. Furthermore, introduction of a constitutively activated form of MEK into hematopoietic stem cells causes myeloid malignancies such as MDS and myeloproliferative neoplasms <a href="#pone.0090992-Chung1" rid="pone.0090992-Chung1" class=" bibr popnode">[11]</a>. Persistant activation of MEK/ERK pathway mediates drug resistance in leukemia cells <a href="#pone.0090992-Naci1" rid="pone.0090992-Naci1" class=" bibr popnode">[12]</a>&#x02013;<a href="#pone.0090992-Suzuki1" rid="pone.0090992-Suzuki1" class=" bibr popnode">[15]</a>. These studies suggest that MEK/ERK pathway may play a role in the development of MDS and in mediating drug resistance.</p><p class="p p-last">In this study, we investigated the effects of BTZ in a human MDS cell line SKM-1. Our results demonstrated that p-ERK1/2 is highly expressed in SKM-1 cells. The expression of p-ERK1/2 was markedly decreased after treatment with BTZ. In contrast, treatment with BTZ resulted in upregulation of ERK in the BTZ-resistant cell line SKM-1R. However, the resistance to BTZ in SKM-1R cells was reversed by the MEK inhibitors U0126 and PD98059. This study provides the first evidence that MEK/ERK pathway mediates BTZ resistance and suggests that MEK/ERK inhibitors could be successfully used in conjunction with BTZ to overcome drug resistance in MDS.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Materials and Methods</h2><div id="s2a" class="sec sec-first"><h3 id="s2atitle">Cell Culture and Reagents</h3><p class="p p-first-last">The human MDS cell line SKM-1 has been described previously <a href="#pone.0090992-Nakagawa1" rid="pone.0090992-Nakagawa1" class=" bibr popnode">[16]</a>. SKM-1 cells were maintained in RPMI &#x02212;1640 with 20% fetal calf serum (HyClone), 100 U/ml penicillin and 100 &#x000b5;g/ml streptomycin in 5% CO<sub>2</sub> at 37&#x000b0;C. The BTZ-resistant SKM-1 cell line was established by repeated exposure of the cells to 5 nM of BTZ for 24 hours followed by 2 weeks recovery over a period of 3 months. MEK inhibitors PD98059 and U0126 were purchased from Cell Signaling Technology.</p></div><div id="s2b" class="sec"><h3 id="s2btitle">MTT Assay</h3><p class="p p-first-last">Cell viability was assessed by the MTT assay. MTT reagent was purchased from Sigma. Human SKM-1 cells were treated with BTZ in 96 well plates at the density of 2&#x000d7;10<sup>4</sup>/well in each experiment. After 24 h, MTT assay was performed. The absorbance was measured at 490 nm by a micro-plate reader (Spectra Max M5).</p></div><div id="s2c" class="sec"><h3 id="s2ctitle">Measurement of Apoptosis and Cell Cycle</h3><p class="p p-first-last">Apoptosis was assessed by flow cytometry (FACS Calibur Flow Cytometer, BD Biosciences) for Annexin V and propidium iodide (PI) staining (kit from Roche). Cells that are positive for Annexin V but negative for PI are considered undergoing apoptosis. Cell cycle analysis was performed by flow cytometry for PI staining (Sigma).</p></div><div id="s2d" class="sec"><h3 id="s2dtitle">Immunoblotting</h3><p class="p p-first-last">SKM-1 cells were washed with PBS and then lysed in a buffer containing 20 mM HEPES (pH 7.2), 10% glycerol, 150 mM NaCl, 1%TritonX-100, 50 mM NaF, 1 mM Na3VO4, 10 ug/ml leupeptin, 10 ug/ml aprotinin, and 1 mM PMSF. Proteins were separated by SDS&#x02013;polyacrylamide gel electrophoresis and blotted onto a PVDF membrane (MILLIPORE). Primary antibodies (Cell Signaling Technology) were directed against Wee1 (1&#x02236;1000), cdc25C (1&#x02236;1000), p-ERK (1&#x02236;1000), ERK (1&#x02236;2000), LC3 (1&#x02236;2000), cleaved caspase-3 (1&#x02236;1000) and GAPDH (1&#x02236;5000). Secondary antibodies were anti-rabbit IgG (1&#x02236;5000, Cell Signaling) and anti-mouse IgG (1&#x02236;5000, Sigma). Antigen&#x02013;antibody complexes were visualized by enhanced chemi- luminescence (PerkinElmer).</p></div><div id="s2e" class="sec"><h3 id="s2etitle">Immunofluorescence</h3><p class="p p-first-last">Cells were fixed with 4% paraformaldehyde and incubated with blocking buffer containing 1% BSA and 0.1% Triton X-100. After blocking, cells were incubated overnight in the primary antibody (cleaved caspase-3, 1&#x02236;400). After washing, cells were incubated in goat anti-rabbit IgG-Alexa Fluor R 568 (Molecular Probes, diluted 1&#x02236;500). Cells were then rinsed and counterstained with DAPI. Images were taken by fluorescence microscope (Leica DM2000).</p></div><div id="s2f" class="sec sec-last"><h3 id="s2ftitle">Statistical Analysis</h3><p class="p p-first-last">Data are presented as means &#x000b1; SD. Student t test was used to determine the significance of the differences between variables. P&#x0003c;0.05 was considered statistically significant.</p></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Result</h2><div id="s3a" class="sec sec-first"><h3 id="s3atitle">BTZ Causes Cell Cycle Arrest in G2/M Phase via Increasing Wee1 Expression</h3><p class="p p-first">The effect of BTZ on cell cycle progression in SKM-1 cells was evaluated using flow cytometric analysis. After treatment with 10 nM BTZ for 24 h, the percentage of cells in G1 and S phases decreased 28% and 29% respectively, whereas the percentage of cells in G2/M phase increased 51% (<a href="/pmc/articles/PMC3946707/figure/pone-0090992-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g001" rid-ob="ob-pone-0090992-g001" co-legend-rid="lgnd_pone-0090992-g001"><span>Fig. 1</span></a>). Our results indicate that BTZ is able to arrest SKM-1 cells at G2/M.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0090992-g001" co-legend-rid="lgnd_pone-0090992-g001"><a href="/pmc/articles/PMC3946707/figure/pone-0090992-g001/" target="figure" rid-figpopup="pone-0090992-g001" rid-ob="ob-pone-0090992-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140715432035200"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3946707_pone.0090992.g001.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0090992.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3946707/bin/pone.0090992.g001.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140715432035200"><a target="object" rel="noopener" href="/pmc/articles/PMC3946707/figure/pone-0090992-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0090992-g001"><div><a class="figpopup" href="/pmc/articles/PMC3946707/figure/pone-0090992-g001/" target="figure" rid-figpopup="pone-0090992-g001" rid-ob="ob-pone-0090992-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>BTZ arrests SKM-1 cells at G2/M phase.</strong><p>A. SKM-1 cells were treated with vehicle (control) or 10 nM BTZ for 24 h and then stained with PI for FACS analysis. B. The distribution of cells in each cell cycle phase is shown. **<em>P</em>&#x0003c;0.01.</p></div></div></div><p class="p">Entry of eukaryotic cells into M-phase of cell cycle is controlled by cdc2 kinase which is activated by cdc25C and inactivated by Wee1. At the G2/M transition, Wee1 is downregulated while cdc25C is upregulated <a href="#pone.0090992-Lew1" rid="pone.0090992-Lew1" class=" bibr popnode">[17]</a>. The finding of a G2/M arrest by BTZ led us to examine the expression levels of Wee1 and cdc25C. <a href="/pmc/articles/PMC3946707/figure/pone-0090992-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g002" rid-ob="ob-pone-0090992-g002" co-legend-rid="lgnd_pone-0090992-g002"><span>Fig. 2</span></a> shows that treatment with 10 nM BTZ for 24 h resulted in increased Wee1 protein expression, while the protein level of cdc25C was not altered. These data suggest that increased Wee1 protein expression contributes to cdc2 inhibition and subsequent G2/M cell cycle arrest following BTZ treatment. Previous studies have shown that cell cycle arrest at G2/M phase often leads to induction of apoptosis and cell death <a href="#pone.0090992-Hiraoka1" rid="pone.0090992-Hiraoka1" class=" bibr popnode">[18]</a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0090992-g002" co-legend-rid="lgnd_pone-0090992-g002"><a href="/pmc/articles/PMC3946707/figure/pone-0090992-g002/" target="figure" rid-figpopup="pone-0090992-g002" rid-ob="ob-pone-0090992-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140715424799248"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3946707_pone.0090992.g002.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0090992.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3946707/bin/pone.0090992.g002.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140715424799248"><a target="object" rel="noopener" href="/pmc/articles/PMC3946707/figure/pone-0090992-g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0090992-g002"><div><a class="figpopup" href="/pmc/articles/PMC3946707/figure/pone-0090992-g002/" target="figure" rid-figpopup="pone-0090992-g002" rid-ob="ob-pone-0090992-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Effect of BTZ on the expression of cell cycle regulatory proteins Wee1 and cdc25C.</strong><p>SKM-1 cells were treated with 10 nM BTZ and the expression of Wee1 and cdc25C was analyzed by immunoblotting. GAPDH was used as loading control.</p></div></div></div></div><div id="s3b" class="sec"><h3 id="s3btitle">BTZ Induced Cell Death in SKM-1 Cells is Mediated by Down-regulation of p-ERK</h3><p class="p p-first">Recent studies showed that BTZ induced apoptosis in plasma cell myeloma cells <a href="#pone.0090992-Manni1" rid="pone.0090992-Manni1" class=" bibr popnode">[19]</a>, <a href="#pone.0090992-Hu1" rid="pone.0090992-Hu1" class=" bibr popnode">[20]</a>. The ability of BTZ to induce apoptosis in SKM-1 cells was evaluated by flow cytometry. As shown in <a href="/pmc/articles/PMC3946707/figure/pone-0090992-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g003" rid-ob="ob-pone-0090992-g003" co-legend-rid="lgnd_pone-0090992-g003"><span>Fig. 3A and 3B</span></a>, at 24 h, BTZ caused an increase of the percentage of apoptotic cells in a concentration-dependent manner. Immunoblot analysis and immunofluorescence staining of cleaved caspase-3 further confirmed apoptosis (<a href="/pmc/articles/PMC3946707/figure/pone-0090992-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g003" rid-ob="ob-pone-0090992-g003" co-legend-rid="lgnd_pone-0090992-g003"><span>Fig. 3C,D</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0090992-g003" co-legend-rid="lgnd_pone-0090992-g003"><a href="/pmc/articles/PMC3946707/figure/pone-0090992-g003/" target="figure" rid-figpopup="pone-0090992-g003" rid-ob="ob-pone-0090992-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140715431710080"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3946707_pone.0090992.g003.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0090992.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3946707/bin/pone.0090992.g003.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140715431710080"><a target="object" rel="noopener" href="/pmc/articles/PMC3946707/figure/pone-0090992-g003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0090992-g003"><div><a class="figpopup" href="/pmc/articles/PMC3946707/figure/pone-0090992-g003/" target="figure" rid-figpopup="pone-0090992-g003" rid-ob="ob-pone-0090992-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>BTZ induces apoptosis.</strong><p>A. Representative flow cytometry scatter plots showing cells undergoing apoptosis in response to BTZ. B. Bar graph shows percentage of SKM-1 cells undergoing apoptosis in response to 5 and 10 nM BTZ for 24 h. C. Immunoblot analysis of cleaved caspase-3. D. Immumofluorescence staining of cleaved caspase-3. Bar 50 &#x000b5;m. *<em>P</em>&#x0003c;0.05.</p></div></div></div><p class="p">It has been shown that BTZ has the capacity to induce autophagic cell death in MDS cells <a href="#pone.0090992-Fang1" rid="pone.0090992-Fang1" class=" bibr popnode">[21]</a>. The induction of autophagy was evaluated in the SKM-1 cells. LC3-II has been used as a marker for autophagy. During induction of autophagy, LC3-I present in the cytoplasm is converted to LC3-II which is membrane bound and correlated with the extent of autophagosome formation <a href="#pone.0090992-Kabeya1" rid="pone.0090992-Kabeya1" class=" bibr popnode">[22]</a>. As shown in <a href="/pmc/articles/PMC3946707/figure/pone-0090992-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g004" rid-ob="ob-pone-0090992-g004" co-legend-rid="lgnd_pone-0090992-g004"><span>Fig. 4</span></a>, an increase of LC3-II levels is evident in BTZ treated cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0090992-g004" co-legend-rid="lgnd_pone-0090992-g004"><a href="/pmc/articles/PMC3946707/figure/pone-0090992-g004/" target="figure" rid-figpopup="pone-0090992-g004" rid-ob="ob-pone-0090992-g004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140715421717024"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3946707_pone.0090992.g004.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0090992.g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3946707/bin/pone.0090992.g004.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140715421717024"><a target="object" rel="noopener" href="/pmc/articles/PMC3946707/figure/pone-0090992-g004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0090992-g004"><div><a class="figpopup" href="/pmc/articles/PMC3946707/figure/pone-0090992-g004/" target="figure" rid-figpopup="pone-0090992-g004" rid-ob="ob-pone-0090992-g004">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>BTZ induces autophagy in SKM-1 cells.</strong><p>SKM-1 cells were treated with 10 nM BTZ for 24 h and immunoblotted for microtubule-associated light chain (LC3-I and LC3-II). GAPDH was used as loading control.</p></div></div></div></div><div id="s3c" class="sec sec-last"><h3 id="s3ctitle">MAPK Inhibitors Overcome BTZ Induced Drug Resistance</h3><p class="p p-first">Given the established role of MAPKs in controlling cell survival, we evaluated if MAPK pathway could be involved in BTZ induced apoptosis. The expression of p-ERK1/2 and total ERK1/2 was analyzed by immunoblotting. SKM-1 cells show constitutively high expression of p-ERK/ERK (<a href="/pmc/articles/PMC3946707/figure/pone-0090992-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g005" rid-ob="ob-pone-0090992-g005" co-legend-rid="lgnd_pone-0090992-g005"><span>Fig. 5</span></a>). Treatment with BTZ dramatically suppressed the expression of p-ERK1/2 but not total ERK1/2 at 24 h (<a href="/pmc/articles/PMC3946707/figure/pone-0090992-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g005" rid-ob="ob-pone-0090992-g005" co-legend-rid="lgnd_pone-0090992-g005"><span>Fig. 5</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0090992-g005" co-legend-rid="lgnd_pone-0090992-g005"><a href="/pmc/articles/PMC3946707/figure/pone-0090992-g005/" target="figure" rid-figpopup="pone-0090992-g005" rid-ob="ob-pone-0090992-g005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140715466137280"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3946707_pone.0090992.g005.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0090992.g005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3946707/bin/pone.0090992.g005.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140715466137280"><a target="object" rel="noopener" href="/pmc/articles/PMC3946707/figure/pone-0090992-g005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0090992-g005"><div><a class="figpopup" href="/pmc/articles/PMC3946707/figure/pone-0090992-g005/" target="figure" rid-figpopup="pone-0090992-g005" rid-ob="ob-pone-0090992-g005">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>ERK1/2 expression in SKM-1 cells.</strong><p>Immunoblotting of SKM-1 cells shows that total and p-ERK1/2 are both expressed in untreated SKM-1 cells (control). However, BTZ inhibited the expression of p-ERK1/2 but not total ERK1/2. GAPDH was used as loading control.</p></div></div></div><p>Most patients who receive the first treatment with BTZ develop resistance to this drug <a href="#pone.0090992-SanMiguel1" rid="pone.0090992-SanMiguel1" class=" bibr popnode">[1]</a>. In order to elucidate the mechanisms of drug resistance, we established a BTZ resistant cell line SKM-1R. <a href="/pmc/articles/PMC3946707/figure/pone-0090992-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g006" rid-ob="ob-pone-0090992-g006" co-legend-rid="lgnd_pone-0090992-g006"><span>Figure 6</span></a> demonstrated the induction of apoptotic cell death in SKM-1 cells treated with 5 nM BTZ by Annexin/PI staining. However, the percentage of cells undergoing apoptosis in BTZ treated SKM-1R cells was not different from the untreated SKM-1R cells. The observation that SKM-1R cells are resistant to BTZ induced apoptosis is consistent with our findings that cell viability did not decrease in BTZ treated SKM-1R cells (<a href="/pmc/articles/PMC3946707/figure/pone-0090992-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g007" rid-ob="ob-pone-0090992-g007" co-legend-rid="lgnd_pone-0090992-g007"><span>Fig. 7</span></a>). Furthermore, activation of autophagy was not observed in SKM-1R cells treated with 5 nM BTZ (<a href="/pmc/articles/PMC3946707/figure/pone-0090992-g008/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g008" rid-ob="ob-pone-0090992-g008" co-legend-rid="lgnd_pone-0090992-g008"><span>Fig. 8</span></a>). We next evaluated the expression of ERK1/2 in SKM-1R cells. In contrast to wild type SKM-1 cells, the expression of both total and phospho-ERK1/2 was upregulated by BTZ in SKM-1R cells (<a href="/pmc/articles/PMC3946707/figure/pone-0090992-g009/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g009" rid-ob="ob-pone-0090992-g009" co-legend-rid="lgnd_pone-0090992-g009"><span>Fig. 9</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0090992-g006" co-legend-rid="lgnd_pone-0090992-g006"><a href="/pmc/articles/PMC3946707/figure/pone-0090992-g006/" target="figure" rid-figpopup="pone-0090992-g006" rid-ob="ob-pone-0090992-g006"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140715429965328"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3946707_pone.0090992.g006.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0090992.g006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3946707/bin/pone.0090992.g006.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140715429965328"><a target="object" rel="noopener" href="/pmc/articles/PMC3946707/figure/pone-0090992-g006/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0090992-g006"><div><a class="figpopup" href="/pmc/articles/PMC3946707/figure/pone-0090992-g006/" target="figure" rid-figpopup="pone-0090992-g006" rid-ob="ob-pone-0090992-g006">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>SKM-1R cells are resistant to BTZ induced apoptosis.</strong><p>A. Flow cytometry scatter plots of the apoptosis assay. B. Bar graph shows percentage of SKM-1 and SKM-1R cells undergoing apoptosis in response to a 24 h treatment with 5 nM BTZ. *<em>P</em>&#x0003c;0.05.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0090992-g007" co-legend-rid="lgnd_pone-0090992-g007"><a href="/pmc/articles/PMC3946707/figure/pone-0090992-g007/" target="figure" rid-figpopup="pone-0090992-g007" rid-ob="ob-pone-0090992-g007"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140715429535728"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3946707_pone.0090992.g007.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0090992.g007.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3946707/bin/pone.0090992.g007.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140715429535728"><a target="object" rel="noopener" href="/pmc/articles/PMC3946707/figure/pone-0090992-g007/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0090992-g007"><div><a class="figpopup" href="/pmc/articles/PMC3946707/figure/pone-0090992-g007/" target="figure" rid-figpopup="pone-0090992-g007" rid-ob="ob-pone-0090992-g007">Figure 7</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Cell viability in response to BTZ treatment.</strong><p>SKM-1 and SKM-1R cells were exposed to 5 nM BTZ for 24 h and the viable cell number was evaluated by MTT assay. The result showed a reduction in cell viability by treating wild type SKM-1 cells with 5 nM BTZ with no notable effect on SKM-1R cells. *<em>P</em>&#x0003c;0.05.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0090992-g008" co-legend-rid="lgnd_pone-0090992-g008"><a href="/pmc/articles/PMC3946707/figure/pone-0090992-g008/" target="figure" rid-figpopup="pone-0090992-g008" rid-ob="ob-pone-0090992-g008"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140715430192688"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3946707_pone.0090992.g008.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0090992.g008.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3946707/bin/pone.0090992.g008.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140715430192688"><a target="object" rel="noopener" href="/pmc/articles/PMC3946707/figure/pone-0090992-g008/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0090992-g008"><div><a class="figpopup" href="/pmc/articles/PMC3946707/figure/pone-0090992-g008/" target="figure" rid-figpopup="pone-0090992-g008" rid-ob="ob-pone-0090992-g008">Figure 8</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Expression of LC3 in BTZ resistant SKM-1R cells.</strong><p>Cell lysates were subjected to immunoblot analysis using specific antibody against LC3. Conversion of LC3-I to LC3-II was not observed in SKM-1R cells treated with BTZ.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0090992-g009" co-legend-rid="lgnd_pone-0090992-g009"><a href="/pmc/articles/PMC3946707/figure/pone-0090992-g009/" target="figure" rid-figpopup="pone-0090992-g009" rid-ob="ob-pone-0090992-g009"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140715429679440"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3946707_pone.0090992.g009.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0090992.g009.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3946707/bin/pone.0090992.g009.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140715429679440"><a target="object" rel="noopener" href="/pmc/articles/PMC3946707/figure/pone-0090992-g009/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0090992-g009"><div><a class="figpopup" href="/pmc/articles/PMC3946707/figure/pone-0090992-g009/" target="figure" rid-figpopup="pone-0090992-g009" rid-ob="ob-pone-0090992-g009">Figure 9</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>ERK1/2 expression in BTZ resistant SKM-1R cells.</strong><p>Immunoblotting of SKM-1R cells shows that both total and phospho-ERK1/2 are upregulated in response to BTZ treatment. Protein expression levels were quantified by ImageJ. Total and phospho-ERK1/2 levels were normalized to GAPDH.</p></div></div></div><p class="p">To further explore the role of MAPK pathway in the development of BTZ resistance in SKM-1R cells, the effects of MAPK inhibitors U0126 and PD98059 on BTZ-induced apoptosis were examined. Flow cytometry analysis showed that resistance to BTZ induced apoptosis was reversed by PD98059 and U0126 (<a href="/pmc/articles/PMC3946707/figure/pone-0090992-g010/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0090992-g010" rid-ob="ob-pone-0090992-g010" co-legend-rid="lgnd_pone-0090992-g010"><span>Fig. 10A,B</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone-0090992-g010" co-legend-rid="lgnd_pone-0090992-g010"><a href="/pmc/articles/PMC3946707/figure/pone-0090992-g010/" target="figure" rid-figpopup="pone-0090992-g010" rid-ob="ob-pone-0090992-g010"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140715415364240"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3946707_pone.0090992.g010.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0090992.g010.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3946707/bin/pone.0090992.g010.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140715415364240"><a target="object" rel="noopener" href="/pmc/articles/PMC3946707/figure/pone-0090992-g010/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0090992-g010"><div><a class="figpopup" href="/pmc/articles/PMC3946707/figure/pone-0090992-g010/" target="figure" rid-figpopup="pone-0090992-g010" rid-ob="ob-pone-0090992-g010">Figure 10</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Reversal of BTZ resistance by MEK inhibitors in SKM-1R cells.</strong><p>A. Flow cytometry scatter plots showing Annexin V staining of SKM-1R cells. B. Bar graph shows percentage of SKM-1R cells undergoing apoptosis in response to a 24 h exposure to 5 nM BTZ. Both PD98059 (PD) and U0126 (U0) significantly increased the percentage of cells undergoing apoptosis. *<em>P</em>&#x0003c;0.05, ***<em>P</em>&#x0003c;0.001.</p></div></div></div></div></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Discussion</h2><p class="p p-first">Despite the clinical success of BTZ in treating plasma cell myeloma, resistance to this drug remains a significant problem <a href="#pone.0090992-SanMiguel1" rid="pone.0090992-SanMiguel1" class=" bibr popnode">[1]</a>. A phase 2 study showed that the rate of response to BTZ was only 35% and patients developed resistance to BTZ 12 months after the initial treatment <a href="#pone.0090992-Richardson1" rid="pone.0090992-Richardson1" class=" bibr popnode">[2]</a>. A recent study showed that only 40% patients with relapsed plasma cell myeloma responded to the retreatment <a href="#pone.0090992-Petrucci1" rid="pone.0090992-Petrucci1" class=" bibr popnode">[3]</a>.</p><p>Significant progress has been made in elucidating molecular mechanisms of BTZ resistance. Oerlemans et al <a href="#pone.0090992-Oerlemans1" rid="pone.0090992-Oerlemans1" class=" bibr popnode">[23]</a> found an Ala49Thr mutation residing in a highly conserved BTZ-binding pocket in the proteasome &#x003b2;5-subunit (PSMB5) protein in BTZ resistant human myelomonocytic THP1 cells. The mutation resulted in overexpression of the PSMB5 protein <a href="#pone.0090992-Oerlemans1" rid="pone.0090992-Oerlemans1" class=" bibr popnode">[23]</a>. Upregulated expression of the PSMB5 gene was confirmed in bone marrow cells of multiple myeloma patients who developed BTZ resistance <a href="#pone.0090992-Shuqing1" rid="pone.0090992-Shuqing1" class=" bibr popnode">[24]</a>. Ria et al <a href="#pone.0090992-Ria1" rid="pone.0090992-Ria1" class=" bibr popnode">[25]</a> suggested that HIF-1&#x003b1; may also play a role in developing BTZ resistance by inducing angiogenesis in tumors. Relative few studies can be found in the literature regarding BTZ and AML. Most of these articles documented the effectiveness of BTZ for a subset of AML patients. BTZ resistant AML cell lines have not been established so far. However, it has been shown that persisting NF-&#x003ba;B activity may be responsible for the survival of CD34(+) AML cells after BTZ treatment <a href="#pone.0090992-Bosman1" rid="pone.0090992-Bosman1" class=" bibr popnode">[26]</a>. When the IKK inhibitor BMS-345541 was used in combination with BTZ, the survival of CD34(+) AML cells was reduced <a href="#pone.0090992-Bosman1" rid="pone.0090992-Bosman1" class=" bibr popnode">[26]</a>, which suggest that NF-kB may be involved in BTZ resistance in AML. Bcl-2 overexpression has been suggested as a potential mechanism of BTZ resistance in human lymphoid cells <a href="#pone.0090992-Smith1" rid="pone.0090992-Smith1" class=" bibr popnode">[27]</a>. Overexpression of heat shock proteins and T-cell factor 4 has been reported in BTZ resistant B-lymphoma cells <a href="#pone.0090992-Shringarpure1" rid="pone.0090992-Shringarpure1" class=" bibr popnode">[28]</a>. Nonetheless, the molecular mechanisms/signaling pathways that mediate BTZ resistance in cancer cells including MDS remain largely unknown.</p><p>In the present study, our data revealed that BTZ resistant SKM-1R cells are characterized by upregulation of ERK. These findings indicate that upregulation of ERK activity may be a potential mechanism for BTZ resistance. MEK/ERK pathway is activated in aggressive CKS1B-overexpressing plasma cell myeloma cells <a href="#pone.0090992-Shi1" rid="pone.0090992-Shi1" class=" bibr popnode">[29]</a>. Higher expression levels of p-ERK in human prostate cancer samples were associated with tumor progression <a href="#pone.0090992-Kinkade1" rid="pone.0090992-Kinkade1" class=" bibr popnode">[30]</a>. Hyperactivation of the MAPK pathway has also been implicated in the development of neurofibromatosis type 1-associated leukemia <a href="#pone.0090992-Staser1" rid="pone.0090992-Staser1" class=" bibr popnode">[31]</a>. Our findings are consistent with these previous reports. We further showed that resistance to BTZ can be reversed by PD98059 and U0126, suggesting that MEK/ERK pathway may be a potential target for MDS patients who developed resistance to BTZ. Our findings are in line with previous report that ERK inhibitors synergized with BTZ on anticancer effects in medulloblastoma cells <a href="#pone.0090992-Yang1" rid="pone.0090992-Yang1" class=" bibr popnode">[32]</a>.</p><p>Using the MUTZ-1 cell line, Huang et al found no notable changes in p-ERK1/2 after BTZ treatment <a href="#pone.0090992-Huang1" rid="pone.0090992-Huang1" class=" bibr popnode">[33]</a>. The difference in p-ERK expression in response to BTZ treatment may be explained by the nature of the two different cell lines. MUTZ-1 was isolated from the malignant cells of a 5-year-old girl with MDS <a href="#pone.0090992-Steube1" rid="pone.0090992-Steube1" class=" bibr popnode">[34]</a>, whereas SKM-1 was established from leukemic cells of a 76-year-old patient <a href="#pone.0090992-Nakagawa1" rid="pone.0090992-Nakagawa1" class=" bibr popnode">[16]</a>. These two cell lines exhibit different chromosome abnormalities.</p><p>Autophagy is a mechanism that degrades dysfunctional cellular components through lysosomes. The activation of autophagy may lead to either cell death or increased survival depending on cell types and conditions. For example, BTZ-induced autophagy led to cell death in MDS/AML cells <a href="#pone.0090992-Fang1" rid="pone.0090992-Fang1" class=" bibr popnode">[21]</a>. Consistent with these previous findings, our present study showed that BTZ induced the conversion of LC3I to LC3II in wild type SKM-1 cells but not in BTZ resistance SKM-1R cells. Our results suggest that autophagic cell death may contribute, at least in part, to BTZ-induced cell cycle arrest and apoptosis.</p><p>In some cases, the LC3-I to LC3-II conversion is necessary but not sufficient to trigger cell autophagy. Further studies are needed to ascertain the role of autophagy in BTZ induced cell death by silencing autophagy related proteins such as ATG5, ATG7 and ATG8 in Skm-1 cells.</p><p class="p p-last">In conclusion, the present study demonstrates that BTZ induces cell cycle arrest, apoptosis and autophagy in SKM-1 cells. The cytotoxic effects of BTZ appeared to depend, at least in part, on the inhibition of the MEK/ERK pathway. The BTZ resistant SKM-1R cells are characterized by upregulation of ERK. Based on the present observations, a combinational therapy of BTZ and MAPK inhibitors may be an effective complement to current therapeutic approaches for MDS.</p></div><div id="funding-group-a.l.b.u" class="tsec sec"><h2 class="head no_bottom_margin" id="funding-group-a.l.b.utitle">Funding Statement</h2><p>This work was supported by the project for the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></div><div id="ref-list-a.n.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.n.atitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0090992-SanMiguel1">1. <span class="mixed-citation">
San-Miguel JF, Richardson PG, Gunther A, Sezer O, Siegel D, et al. (2013) <span class="ref-title">Phase ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma</span>. <span class="ref-journal">J Clin Oncol</span>
<span class="ref-vol">31</span>: 3696&#x02013;3703. [<a href="https://pubmed.ncbi.nlm.nih.gov/24019544" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Phase+ib+study+of+panobinostat+and+bortezomib+in+relapsed+or+relapsed+and+refractory+multiple+myeloma&amp;author=JF+San-Miguel&amp;author=PG+Richardson&amp;author=A+Gunther&amp;author=O+Sezer&amp;author=D+Siegel&amp;volume=31&amp;publication_year=2013&amp;pages=3696-3703&amp;pmid=24019544&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Richardson1">2. <span class="mixed-citation">
Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, et al. (2003) <span class="ref-title">A phase 2 study of bortezomib in relapsed, refractory myeloma</span>. <span class="ref-journal">N Engl J Med</span>
<span class="ref-vol">348</span>: 2609&#x02013;2617. [<a href="https://pubmed.ncbi.nlm.nih.gov/12826635" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+phase+2+study+of+bortezomib+in+relapsed,+refractory+myeloma&amp;author=PG+Richardson&amp;author=B+Barlogie&amp;author=J+Berenson&amp;author=S+Singhal&amp;author=S+Jagannath&amp;volume=348&amp;publication_year=2003&amp;pages=2609-2617&amp;pmid=12826635&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Petrucci1">3. <span class="mixed-citation">
Petrucci MT, Giraldo P, Corradini P, Teixeira A, Dimopoulos MA, et al. (2013) <span class="ref-title">A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma</span>. <span class="ref-journal">Br J Haematol</span>
<span class="ref-vol">160</span>: 649&#x02013;659. [<a href="https://pubmed.ncbi.nlm.nih.gov/23293914" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=A+prospective,+international+phase+2+study+of+bortezomib+retreatment+in+patients+with+relapsed+multiple+myeloma&amp;author=MT+Petrucci&amp;author=P+Giraldo&amp;author=P+Corradini&amp;author=A+Teixeira&amp;author=MA+Dimopoulos&amp;volume=160&amp;publication_year=2013&amp;pages=649-659&amp;pmid=23293914&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Attar1">4. <span class="mixed-citation">
Attar EC, Amrein PC, Fraser JW, Fathi AT, McAfee S, et al. (2013) <span class="ref-title">Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)</span>. <span class="ref-journal">Leuk Res</span>
<span class="ref-vol">37</span>: 1016&#x02013;1020. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3969839/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23773898" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leuk+Res&amp;title=Phase+I+dose+escalation+study+of+bortezomib+in+combination+with+lenalidomide+in+patients+with+myelodysplastic+syndromes+(MDS)+and+acute+myeloid+leukemia+(AML)&amp;author=EC+Attar&amp;author=PC+Amrein&amp;author=JW+Fraser&amp;author=AT+Fathi&amp;author=S+McAfee&amp;volume=37&amp;publication_year=2013&amp;pages=1016-1020&amp;pmid=23773898&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Howard1">5. <span class="mixed-citation">
Howard DS, Liesveld J, Phillips GL 2nd, Hayslip J, Weiss H, et al. (2013) <span class="ref-title">A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia</span>. <span class="ref-journal">Leuk Res</span>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4025941/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24075534" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leuk+Res&amp;title=A+phase+I+study+using+bortezomib+with+weekly+idarubicin+for+treatment+of+elderly+patients+with+acute+myeloid+leukemia&amp;author=DS+Howard&amp;author=J+Liesveld&amp;author=GL+Phillips&amp;author=J+Hayslip&amp;author=H+Weiss&amp;publication_year=2013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Wang1">6. <span class="mixed-citation">
Wang AH, Wei L, Chen L, Zhao SQ, Wu WL, et al. (2011) <span class="ref-title">Synergistic effect of bortezomib and valproic acid treatment on the proliferation and apoptosis of acute myeloid leukemia and myelodysplastic syndrome cells</span>. <span class="ref-journal">Ann Hematol</span>
<span class="ref-vol">90</span>: 917&#x02013;931. [<a href="https://pubmed.ncbi.nlm.nih.gov/21340723" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Hematol&amp;title=Synergistic+effect+of+bortezomib+and+valproic+acid+treatment+on+the+proliferation+and+apoptosis+of+acute+myeloid+leukemia+and+myelodysplastic+syndrome+cells&amp;author=AH+Wang&amp;author=L+Wei&amp;author=L+Chen&amp;author=SQ+Zhao&amp;author=WL+Wu&amp;volume=90&amp;publication_year=2011&amp;pages=917-931&amp;pmid=21340723&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-NatarajanAme1">7. <span class="mixed-citation">
Natarajan-Ame S, Park S, Ades L, Vey N, Guerci-Bresler A, et al. (2012) <span class="ref-title">Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM</span>. <span class="ref-journal">Br J Haematol</span>
<span class="ref-vol">158</span>: 232&#x02013;237. [<a href="https://pubmed.ncbi.nlm.nih.gov/22571447" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=Bortezomib+combined+with+low-dose+cytarabine+in+Intermediate-2+and+high+risk+myelodysplastic+syndromes.+A+phase+I/II+Study+by+the+GFM&amp;author=S+Natarajan-Ame&amp;author=S+Park&amp;author=L+Ades&amp;author=N+Vey&amp;author=A+Guerci-Bresler&amp;volume=158&amp;publication_year=2012&amp;pages=232-237&amp;pmid=22571447&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Ricciardi1">8. <span class="mixed-citation">
Ricciardi MR, McQueen T, Chism D, Milella M, Estey E, et al. (2005) <span class="ref-title">Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia</span>. <span class="ref-journal">Leukemia</span>
<span class="ref-vol">19</span>: 1543&#x02013;1549. [<a href="https://pubmed.ncbi.nlm.nih.gov/16001087" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Quantitative+single+cell+determination+of+ERK+phosphorylation+and+regulation+in+relapsed+and+refractory+primary+acute+myeloid+leukemia&amp;author=MR+Ricciardi&amp;author=T+McQueen&amp;author=D+Chism&amp;author=M+Milella&amp;author=E+Estey&amp;volume=19&amp;publication_year=2005&amp;pages=1543-1549&amp;pmid=16001087&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Kornblau1">9. <span class="mixed-citation">
Kornblau SM, Womble M, Qiu YH, Jackson CE, Chen W, et al. (2006) <span class="ref-title">Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia</span>. <span class="ref-journal">Blood</span>
<span class="ref-vol">108</span>: 2358&#x02013;2365. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1895551/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16763210" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Simultaneous+activation+of+multiple+signal+transduction+pathways+confers+poor+prognosis+in+acute+myelogenous+leukemia&amp;author=SM+Kornblau&amp;author=M+Womble&amp;author=YH+Qiu&amp;author=CE+Jackson&amp;author=W+Chen&amp;volume=108&amp;publication_year=2006&amp;pages=2358-2365&amp;pmid=16763210&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Shelton1">10. <span class="mixed-citation">
Shelton JG, Steelman LS, Abrams SL, Bertrand FE, Franklin RA, et al. (2005) <span class="ref-title">The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what&#x02019;s genetics got to do with it?</span>
<span class="ref-journal">Expert Opin Ther Targets</span>
<span class="ref-vol">9</span>: 1009&#x02013;1030. [<a href="https://pubmed.ncbi.nlm.nih.gov/16185155" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Ther+Targets&amp;title=The+epidermal+growth+factor+receptor+gene+family+as+a+target+for+therapeutic+intervention+in+numerous+cancers:+what&#x02019;s+genetics+got+to+do+with+it?&amp;author=JG+Shelton&amp;author=LS+Steelman&amp;author=SL+Abrams&amp;author=FE+Bertrand&amp;author=RA+Franklin&amp;volume=9&amp;publication_year=2005&amp;pages=1009-1030&amp;pmid=16185155&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Chung1">11. <span class="mixed-citation">
Chung E, Hsu CL, Kondo M (2011) <span class="ref-title">Constitutive MAP kinase activation in hematopoietic stem cells induces a myeloproliferative disorder</span>. <span class="ref-journal">PLoS One</span>
<span class="ref-vol">6</span>: e28350. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3229546/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22164275" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Constitutive+MAP+kinase+activation+in+hematopoietic+stem+cells+induces+a+myeloproliferative+disorder&amp;author=E+Chung&amp;author=CL+Hsu&amp;author=M+Kondo&amp;volume=6&amp;publication_year=2011&amp;pages=e28350&amp;pmid=22164275&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Naci1">12. <span class="mixed-citation">
Naci D, El Azreq MA, Chetoui N, Lauden L, Sigaux F, et al. (2012) <span class="ref-title">alpha2beta1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK)</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">287</span>: 17065&#x02013;17076. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3366820/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22457358" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=alpha2beta1+integrin+promotes+chemoresistance+against+doxorubicin+in+cancer+cells+through+extracellular+signal-regulated+kinase+(ERK)&amp;author=D+Naci&amp;author=MA+El+Azreq&amp;author=N+Chetoui&amp;author=L+Lauden&amp;author=F+Sigaux&amp;volume=287&amp;publication_year=2012&amp;pages=17065-17076&amp;pmid=22457358&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Fenouille1">13. <span class="mixed-citation">
Fenouille N, Puissant A, Dufies M, Robert G, Jacquel A, et al. (2010) <span class="ref-title">Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC</span>. <span class="ref-journal">Cancer Res</span>
<span class="ref-vol">70</span>: 9659&#x02013;9670. [<a href="https://pubmed.ncbi.nlm.nih.gov/21098700" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Persistent+activation+of+the+Fyn/ERK+kinase+signaling+axis+mediates+imatinib+resistance+in+chronic+myelogenous+leukemia+cells+through+upregulation+of+intracellular+SPARC&amp;author=N+Fenouille&amp;author=A+Puissant&amp;author=M+Dufies&amp;author=G+Robert&amp;author=A+Jacquel&amp;volume=70&amp;publication_year=2010&amp;pages=9659-9670&amp;pmid=21098700&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Abrams1">14. <span class="mixed-citation">
Abrams SL, Steelman LS, Shelton JG, Wong EW, Chappell WH, et al. (2010) <span class="ref-title">The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy</span>. <span class="ref-journal">Cell Cycle</span>
<span class="ref-vol">9</span>: 1781&#x02013;1791. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3781182/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20436278" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Cycle&amp;title=The+Raf/MEK/ERK+pathway+can+govern+drug+resistance,+apoptosis+and+sensitivity+to+targeted+therapy&amp;author=SL+Abrams&amp;author=LS+Steelman&amp;author=JG+Shelton&amp;author=EW+Wong&amp;author=WH+Chappell&amp;volume=9&amp;publication_year=2010&amp;pages=1781-1791&amp;pmid=20436278&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Suzuki1">15. <span class="mixed-citation">
Suzuki M, Abe A, Imagama S, Nomura Y, Tanizaki R, et al. (2010) <span class="ref-title">BCR-ABL-independent and RAS/MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4</span>. <span class="ref-journal">Eur J Haematol</span>
<span class="ref-vol">84</span>: 229&#x02013;238. [<a href="https://pubmed.ncbi.nlm.nih.gov/20002159" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Haematol&amp;title=BCR-ABL-independent+and+RAS/MAPK+pathway-dependent+form+of+imatinib+resistance+in+Ph-positive+acute+lymphoblastic+leukemia+cell+line+with+activation+of+EphB4&amp;author=M+Suzuki&amp;author=A+Abe&amp;author=S+Imagama&amp;author=Y+Nomura&amp;author=R+Tanizaki&amp;volume=84&amp;publication_year=2010&amp;pages=229-238&amp;pmid=20002159&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Nakagawa1">16. <span class="mixed-citation">
Nakagawa T, Matozaki S, Murayama T, Nishimura R, Tsutsumi M, et al. (1993) <span class="ref-title">Establishment of a leukaemic cell line from a patient with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndrome</span>. <span class="ref-journal">Br J Haematol</span>
<span class="ref-vol">85</span>: 469&#x02013;476. [<a href="https://pubmed.ncbi.nlm.nih.gov/8136267" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=Establishment+of+a+leukaemic+cell+line+from+a+patient+with+acquisition+of+chromosomal+abnormalities+during+disease+progression+in+myelodysplastic+syndrome&amp;author=T+Nakagawa&amp;author=S+Matozaki&amp;author=T+Murayama&amp;author=R+Nishimura&amp;author=M+Tsutsumi&amp;volume=85&amp;publication_year=1993&amp;pages=469-476&amp;pmid=8136267&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Lew1">17. <span class="mixed-citation">
Lew DJ, Kornbluth S (1996) <span class="ref-title">Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control</span>. <span class="ref-journal">Curr Opin Cell Biol</span>
<span class="ref-vol">8</span>: 795&#x02013;804. [<a href="https://pubmed.ncbi.nlm.nih.gov/8939679" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Cell+Biol&amp;title=Regulatory+roles+of+cyclin+dependent+kinase+phosphorylation+in+cell+cycle+control&amp;author=DJ+Lew&amp;author=S+Kornbluth&amp;volume=8&amp;publication_year=1996&amp;pages=795-804&amp;pmid=8939679&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Hiraoka1">18. <span class="mixed-citation">
Hiraoka Y, Yamada T, Goto M, Das Gupta TK, Chakrabarty AM (2004) <span class="ref-title">Modulation of mammalian cell growth and death by prokaryotic and eukaryotic cytochrome c</span>. <span class="ref-journal">Proc Natl Acad Sci U S A</span>
<span class="ref-vol">101</span>: 6427&#x02013;6432. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC404061/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15082831" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Modulation+of+mammalian+cell+growth+and+death+by+prokaryotic+and+eukaryotic+cytochrome+c&amp;author=Y+Hiraoka&amp;author=T+Yamada&amp;author=M+Goto&amp;author=TK+Das+Gupta&amp;author=AM+Chakrabarty&amp;volume=101&amp;publication_year=2004&amp;pages=6427-6432&amp;pmid=15082831&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Manni1">19. <span class="mixed-citation">
Manni S, Brancalion A, Mandato E, Tubi LQ, Colpo A, et al. (2013) <span class="ref-title">Protein Kinase CK2 Inhibition Down Modulates the NF-kappaB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells</span>. <span class="ref-journal">PLoS One</span>
<span class="ref-vol">8</span>: e75280. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3785505/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24086494" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Protein+Kinase+CK2+Inhibition+Down+Modulates+the+NF-kappaB+and+STAT3+Survival+Pathways,+Enhances+the+Cellular+Proteotoxic+Stress+and+Synergistically+Boosts+the+Cytotoxic+Effect+of+Bortezomib+on+Multiple+Myeloma+and+Mantle+Cell+Lymphoma+Cells&amp;author=S+Manni&amp;author=A+Brancalion&amp;author=E+Mandato&amp;author=LQ+Tubi&amp;author=A+Colpo&amp;volume=8&amp;publication_year=2013&amp;pages=e75280&amp;pmid=24086494&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Hu1">20. <span class="mixed-citation">
Hu J, Van Valckenborgh E, Xu D, Menu E, De Raeve H, et al. (2013) <span class="ref-title">Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro</span>. <span class="ref-journal">Mol Cancer Ther</span>
<span class="ref-vol">12</span>: 1763&#x02013;1773. [<a href="https://pubmed.ncbi.nlm.nih.gov/23832122" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Ther&amp;title=Synergistic+induction+of+apoptosis+in+multiple+myeloma+cells+by+bortezomib+and+hypoxia-activated+prodrug+TH-302,+in+vivo+and+in+vitro&amp;author=J+Hu&amp;author=E+Van+Valckenborgh&amp;author=D+Xu&amp;author=E+Menu&amp;author=H+De+Raeve&amp;volume=12&amp;publication_year=2013&amp;pages=1763-1773&amp;pmid=23832122&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Fang1">21. <span class="mixed-citation">
Fang J, Rhyasen G, Bolanos L, Rasch C, Varney M, et al. (2012) <span class="ref-title">Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1</span>. <span class="ref-journal">Blood</span>
<span class="ref-vol">120</span>: 858&#x02013;867. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3412348/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22685174" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Cytotoxic+effects+of+bortezomib+in+myelodysplastic+syndrome/acute+myeloid+leukemia+depend+on+autophagy-mediated+lysosomal+degradation+of+TRAF6+and+repression+of+PSMA1&amp;author=J+Fang&amp;author=G+Rhyasen&amp;author=L+Bolanos&amp;author=C+Rasch&amp;author=M+Varney&amp;volume=120&amp;publication_year=2012&amp;pages=858-867&amp;pmid=22685174&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Kabeya1">22. <span class="mixed-citation">
Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) <span class="ref-title">LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing</span>. <span class="ref-journal">EMBO J</span>
<span class="ref-vol">19</span>: 5720&#x02013;5728. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC305793/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11060023" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+J&amp;title=LC3,+a+mammalian+homologue+of+yeast+Apg8p,+is+localized+in+autophagosome+membranes+after+processing&amp;author=Y+Kabeya&amp;author=N+Mizushima&amp;author=T+Ueno&amp;author=A+Yamamoto&amp;author=T+Kirisako&amp;volume=19&amp;publication_year=2000&amp;pages=5720-5728&amp;pmid=11060023&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Oerlemans1">23. <span class="mixed-citation">
Oerlemans R, Franke NE, Assaraf YG, Cloos J, van Zantwijk I, et al. (2008) <span class="ref-title">Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein</span>. <span class="ref-journal">Blood</span>
<span class="ref-vol">112</span>: 2489&#x02013;2499. [<a href="https://pubmed.ncbi.nlm.nih.gov/18565852" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Molecular+basis+of+bortezomib+resistance:+proteasome+subunit+beta5+(PSMB5)+gene+mutation+and+overexpression+of+PSMB5+protein&amp;author=R+Oerlemans&amp;author=NE+Franke&amp;author=YG+Assaraf&amp;author=J+Cloos&amp;author=I+van+Zantwijk&amp;volume=112&amp;publication_year=2008&amp;pages=2489-2499&amp;pmid=18565852&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Shuqing1">24. <span class="mixed-citation">
Shuqing L, Jianmin Y, Chongmei H, Hui C, Wang J (2011) <span class="ref-title">Upregulated expression of the PSMB5 gene may contribute to drug resistance in patient with multiple myeloma when treated with bortezomib-based regimen</span>. <span class="ref-journal">Exp Hematol</span>
<span class="ref-vol">39</span>: 1117&#x02013;1118. [<a href="https://pubmed.ncbi.nlm.nih.gov/21920470" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Hematol&amp;title=Upregulated+expression+of+the+PSMB5+gene+may+contribute+to+drug+resistance+in+patient+with+multiple+myeloma+when+treated+with+bortezomib-based+regimen&amp;author=L+Shuqing&amp;author=Y+Jianmin&amp;author=H+Chongmei&amp;author=C+Hui&amp;author=J+Wang&amp;volume=39&amp;publication_year=2011&amp;pages=1117-1118&amp;pmid=21920470&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Ria1">25. <span class="mixed-citation">
Ria R, Catacchio I, Berardi S, De Luisi A, Caivano A, et al. (2013) <span class="ref-title">HIF-1alpha of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target</span>. <span class="ref-journal">Clin Cancer Res</span>. [<a href="https://pubmed.ncbi.nlm.nih.gov/24297864" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=HIF-1alpha+of+bone+marrow+endothelial+cells+implies+relapse+and+drug+resistance+in+patients+with+multiple+myeloma+and+may+act+as+a+therapeutic+target&amp;author=R+Ria&amp;author=I+Catacchio&amp;author=S+Berardi&amp;author=A+De+Luisi&amp;author=A+Caivano&amp;publication_year=2013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Bosman1">26. <span class="mixed-citation">Bosman MC, Schuringa JJ, Quax WJ, Vellenga E (2013) Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-kappaB and the accumulation of MCL-1. Exp Hematol 41: 530&#x02013;538 e531. [<a href="https://pubmed.ncbi.nlm.nih.gov/23416210" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Smith1">27. <span class="mixed-citation">
Smith AJ, Dai H, Correia C, Takahashi R, Lee SH, et al. (2011) <span class="ref-title">Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">286</span>: 17682&#x02013;17692. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3093844/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21454712" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Noxa/Bcl-2+protein+interactions+contribute+to+bortezomib+resistance+in+human+lymphoid+cells&amp;author=AJ+Smith&amp;author=H+Dai&amp;author=C+Correia&amp;author=R+Takahashi&amp;author=SH+Lee&amp;volume=286&amp;publication_year=2011&amp;pages=17682-17692&amp;pmid=21454712&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Shringarpure1">28. <span class="mixed-citation">
Shringarpure R, Catley L, Bhole D, Burger R, Podar K, et al. (2006) <span class="ref-title">Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib</span>. <span class="ref-journal">Br J Haematol</span>
<span class="ref-vol">134</span>: 145&#x02013;156. [<a href="https://pubmed.ncbi.nlm.nih.gov/16846475" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=Gene+expression+analysis+of+B-lymphoma+cells+resistant+and+sensitive+to+bortezomib&amp;author=R+Shringarpure&amp;author=L+Catley&amp;author=D+Bhole&amp;author=R+Burger&amp;author=K+Podar&amp;volume=134&amp;publication_year=2006&amp;pages=145-156&amp;pmid=16846475&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Shi1">29. <span class="mixed-citation">
Shi L, Wang S, Zangari M, Xu H, Cao TM, et al. (2010) <span class="ref-title">Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance</span>. <span class="ref-journal">Oncotarget</span>
<span class="ref-vol">1</span>: 22&#x02013;33. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2949973/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20930946" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Over-expression+of+CKS1B+activates+both+MEK/ERK+and+JAK/STAT3+signaling+pathways+and+promotes+myeloma+cell+drug-resistance&amp;author=L+Shi&amp;author=S+Wang&amp;author=M+Zangari&amp;author=H+Xu&amp;author=TM+Cao&amp;volume=1&amp;publication_year=2010&amp;pages=22-33&amp;pmid=20930946&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Kinkade1">30. <span class="mixed-citation">
Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, et al. (2008) <span class="ref-title">Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model</span>. <span class="ref-journal">J Clin Invest</span>
<span class="ref-vol">118</span>: 3051&#x02013;3064. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2518074/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18725989" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Targeting+AKT/mTOR+and+ERK+MAPK+signaling+inhibits+hormone-refractory+prostate+cancer+in+a+preclinical+mouse+model&amp;author=CW+Kinkade&amp;author=M+Castillo-Martin&amp;author=A+Puzio-Kuter&amp;author=J+Yan&amp;author=TH+Foster&amp;volume=118&amp;publication_year=2008&amp;pages=3051-3064&amp;pmid=18725989&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Staser1">31. <span class="mixed-citation">
Staser K, Park SJ, Rhodes SD, Zeng Y, He YZ, et al. (2013) <span class="ref-title">Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk</span>. <span class="ref-journal">J Clin Invest</span>
<span class="ref-vol">123</span>: 329&#x02013;334. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3533306/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23221339" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Normal+hematopoiesis+and+neurofibromin-deficient+myeloproliferative+disease+require+Erk&amp;author=K+Staser&amp;author=SJ+Park&amp;author=SD+Rhodes&amp;author=Y+Zeng&amp;author=YZ+He&amp;volume=123&amp;publication_year=2013&amp;pages=329-334&amp;pmid=23221339&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Yang1">32. <span class="mixed-citation">
Yang F, Jove V, Chang S, Hedvat M, Liu L, et al. (2012) <span class="ref-title">Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-kB signaling, and synergizes with an ERK inhibitor</span>. <span class="ref-journal">Cancer Biol Ther</span>
<span class="ref-vol">13</span>: 349&#x02013;357. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3341212/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22313636" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol+Ther&amp;title=Bortezomib+induces+apoptosis+and+growth+suppression+in+human+medulloblastoma+cells,+associated+with+inhibition+of+AKT+and+NF-kB+signaling,+and+synergizes+with+an+ERK+inhibitor&amp;author=F+Yang&amp;author=V+Jove&amp;author=S+Chang&amp;author=M+Hedvat&amp;author=L+Liu&amp;volume=13&amp;publication_year=2012&amp;pages=349-357&amp;pmid=22313636&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Huang1">33. <span class="mixed-citation">
Huang J, Ding T, Yang M, Liu H, Sun X, et al. (2011) <span class="ref-title">Antitumor activity and drug interactions of proteasome inhibitor Bortezomib in human high-risk myelodysplastic syndrome cells</span>. <span class="ref-journal">Int J Hematol</span>
<span class="ref-vol">93</span>: 482&#x02013;493. [<a href="https://pubmed.ncbi.nlm.nih.gov/21451957" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Hematol&amp;title=Antitumor+activity+and+drug+interactions+of+proteasome+inhibitor+Bortezomib+in+human+high-risk+myelodysplastic+syndrome+cells&amp;author=J+Huang&amp;author=T+Ding&amp;author=M+Yang&amp;author=H+Liu&amp;author=X+Sun&amp;volume=93&amp;publication_year=2011&amp;pages=482-493&amp;pmid=21451957&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0090992-Steube1">34. <span class="mixed-citation">
Steube KG, Gignac SM, Hu ZB, Teepe D, Harms D, et al. (1997) <span class="ref-title">In vitro culture studies of childhood myelodysplastic syndrome: establishment of the cell line MUTZ-1</span>. <span class="ref-journal">Leuk Lymphoma</span>
<span class="ref-vol">25</span>: 345&#x02013;363. [<a href="https://pubmed.ncbi.nlm.nih.gov/9168445" ref="reftype=pubmed&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leuk+Lymphoma&amp;title=In+vitro+culture+studies+of+childhood+myelodysplastic+syndrome:+establishment+of+the+cell+line+MUTZ-1&amp;author=KG+Steube&amp;author=SM+Gignac&amp;author=ZB+Hu&amp;author=D+Teepe&amp;author=D+Harms&amp;volume=25&amp;publication_year=1997&amp;pages=345-363&amp;pmid=9168445&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3946707&amp;issue-id=234507&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">PLOS ONE</span> are provided here courtesy of <strong>PLOS</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3946707/pdf/pone.0090992.pdf" class="int-view">PDF (1.0M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3946707/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3946707/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3946707" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3946707%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="mwfYh1glPjDRq4XH8ffDttYvrMTFxvYzhR8F0yaZqkrko8gmI6lcxasPddQlIpHv">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3946707%2F&amp;text=Reversal%20of%20Bortezomib%20Resistance%20in%20Myelodysplastic%20Syndrome%20Cells%20by%20MAPK%20Inhibitors" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3946707%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946707/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3946707/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/24608798/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3946707/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/24608798/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3946707/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3946707/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC3946707/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
